Monopar Therapeutics股票讨论区

$Monopar Therapeutics (MNPR.US)$ 2024年9月30日结束的第三季度结果与2023年9月30日结束的第三季度结果进行比较
 
现金及净损失
 
Cash and cash equivalents as of September 30, 2024, were $600万. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $1770万, after deducting placement agent fees and other estimated offering expenses.
 
Monopar project...

$Monopar Therapeutics (MNPR.US)$ monopar therapeutics：认为目前所有基金类型足够继续运营至少到2026年上半年

$Monopar Therapeutics (MNPR.US)$ 你真的在努力吗？还是在逗我？嘿嘿嘿

$Monopar Therapeutics (MNPR.US)$
有人能告诉我应该买入哪支股票以获得利润吗？因为我之前持有的只能给我4至5%的回报。

$Monopar Therapeutics (MNPR.US)$ 没有主力，这只没啥动力了。。。

$Monopar Therapeutics (MNPR.US)$ 卖出普通股票。当然！

$ImmunityBio (IBRX.US)$
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
也在增强投资组合…….
and
and
and
are also doing ok (beyond the obvious $特斯拉 (TSLA.US)$ , $英伟达 (NVDA.US)$ 和 $MicroStrategy (MSTR.US)$ .

$Monopar Therapeutics (MNPR.US)$ 应该下跌？

$Monopar Therapeutics (MNPR.US)$ 保持在这里，可能会再次出现反弹